Photo

Reuters Photojournalism

Our day's top images, in-depth photo essays and offbeat slices of life. See the best of Reuters photography.  See more | Photo caption 

Photo

Rage in Brazil

Mass protests erupt in the biggest cities of Brazil.  Slideshow 

Photo

The Afghan Army

The many faces of the Afghan National Army, which has taken over security of the country from NATO.  Slideshow 

Sponsored Links

Wall Street drops on tech warnings; P&G cuts Dow's loss

Traders work on the floor of the New York Stock Exchange, July 10, 2012. REUTERS/Brendan McDermid

Traders work on the floor of the New York Stock Exchange, July 10, 2012.

Credit: Reuters/Brendan McDermid

NEW YORK | Thu Jul 12, 2012 6:13pm EDT

NEW YORK (Reuters) - U.S. stocks fell on Thursday, hit by more warnings in the technology sector, while a rally in Procter & Gamble (PG.N) helped the blue-chip Dow cut its loss.

Shares of consumer products giant Procter & Gamble (PG.N) rose 3.7 percent to $63.70 after a source said activist investor William Ackman appears to be building a stake in the U.S. household products company. Despite the support, the Dow ended lower for a sixth day.

Tech shares remained under pressure, with the S&P technology sector index down 3.5 percent for the month so far. Indian IT heavyweight Infosys Ltd (INFY.NS)INFY.O became the latest big tech company to warn of sluggish sales, saying global economic uncertainty was hitting technology spending.

U.S.-listed shares of Infosys slid 11.2 percent to $38.75, after earlier dropping to an all-time low of $38.12.

"I think it is the fear that technology companies are going to miss estimates" this earnings period, said Bruce Zaro, chief technical strategist at Delta Global Asset Management in Boston.

Profit warnings from companies such as Advanced Micro Devices Inc (AMD.N) have hurt the sector in recent days. The S&P tech sector index .GSPT ended Thursday down 1.1 percent.

All three major U.S. stock indexes recovered from their lows of the day, with the S&P 500 bouncing off its 50-day moving average at 1,334 and the Dow briefly trading higher after hitting technical support at 12,500, analysts said.

Merck & Co. (MRK.N) shares also bolstered the Dow. Merck's stock rose 4.1 percent to $42.91 after a pivotal trial of Merck's experimental osteoporosis drug odanacatib has shown that it reduces the risk of fracture.

The Dow Jones industrial average .DJI shed 31.26 points, or 0.25 percent, to 12,573.27 at the close. The Standard & Poor's 500 Index .SPX shed 6.69 points, or 0.50 percent, to 1,334.76. The Nasdaq Composite Index .IXIC lost 21.79 points, or 0.75 percent, to close at 2,866.19.

The Dow has lost 2.9 percent since its close on July 3.

Overall market sentiment was weak, especially after the lack of any monetary easing by the Bank of Japan on Thursday, and few clues on Wednesday in the minutes from the Federal Reserve's June policy meeting. The lack of policy moves suggested major central banks were still cautious about the need for further easing.

On the earnings front, Bank of America Merrill Lynch Global Research lowered its forecast on the S&P 500's 2012 earnings per share to $102 from $103.50, and for 2013, to $109 from $110.50.

The forecasts were cut "to reflect the impact of lower commodity prices and slower global growth on corporate profits," BofA Merrill Lynch Global Research analysts said in a note.

Hotel operator Marriott International Inc (MAR.N) reported a higher quarterly profit after Wednesday's close, but cut its fee revenue forecast due to weakness in some international markets. Its stock slid 6.4 percent to $35.58.

Data on the economy showed some promising signs, however. Initial claims for state unemployment benefits in the United States dropped to the lowest in four years.

Other economic data showed U.S. June import prices fell 2.7 percent, the most in more than three years, due to a plunge in the cost of imported oil, further icing inflation pressures.

Volume was a bit lighter than average. About 6.46 billion shares changed hands on the New York Stock Exchange, the Nasdaq and Amex, compared with the year-to-date daily average of 6.85 billion shares.

Decliners beat advancers by a ratio of about 19 to 11 on the NYSE and on the Nasdaq, by about 3 to 2.

(Additional reporting by Leah Schnurr and Angela Moon; Editing by Jan Paschal)

We welcome comments that advance the story through relevant opinion, anecdotes, links and data. If you see a comment that you believe is irrelevant or inappropriate, you can flag it to our editors by using the report abuse links. Views expressed in the comments do not represent those of Reuters. For more information on our comment policy, see http://blogs.reuters.com/fulldisclosure/2010/09/27/toward-a-more-thoughtful-conversation-on-stories/
Comments (1)
Slammy wrote:
Is it me or does this seems like the headline every other week? Next week their are going to reports that the new European bail out has calmed investors and growth is seen again then the week after everyone will be worried again… back and forth, back and forth..

Jul 12, 2012 12:49pm EDT  --  Report as abuse
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.